AnticoagEvaluator vs. MAQI2 Anticoagulation Toolkit Utilizzo e statistiche

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

AnticoagEvaluatorRanking a confronto con MAQI2 Anticoagulation Toolkit

Confronta la tendenza di classifica AnticoagEvaluator nei ultimi 28 giorni rispetto a MAQI2 Anticoagulation Toolkit

Rank

Nessun dato disponibile

Classifica AnticoagEvaluator vs. MAQI2 Anticoagulation Toolkit per paese a confronto

Confronta la tendenza di classifica AnticoagEvaluator nei ultimi 28 giorni rispetto a MAQI2 Anticoagulation Toolkit

Nessun dato da visualizzare

Fai confronti con qualsiasi sito con la nostra prova gratuita

Inizia
AnticoagEvaluator VS.
MAQI2 Anticoagulation Toolkit

19icembre d, 2024